In addition, the results of cell scratch, migration and invasion and western blot showed that SKL2001 treatment after MAL2 knockdown could partially reverse the effects of MAL2 silencing on migration, invasion and EMT progression, suggesting that β-catenin was involved in the regulation of MAL2 on BC progression. The gene discussed is MAL2; the disease is breast cancer.